Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists
US11987586B1 · kind B1 · utility
0Cited by
13References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2023 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Oct 30, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.